Title: Evaluation of Knowledge, Attitude and Practices of Resident Doctors, Interns and Nurses on Adverse Drug Reaction Monitoring and Reporting In a Tertiary Care Hospital
Authors: Rohini P.Jagtap, Rajesh R.Todkar, Kalpita G.Gawit, Balasaheb B.Ghongane
DOI: https://dx.doi.org/10.18535/jmscr/v5i3.120
Abstract
Objective:- To assess the knowledge, attitude and practices regarding adverse drug reaction (ADR) reporting as well as to evaluate the barriers involved in non-reporting of suspected ADRs in Resident doctors , Interns and Nurses at tertiary care hospital.
Methods: A prospective, cross sectional, questionnaire based study was conducted in 158 Interns ,75 Resident doctors and 60 Nurses at a tertiary care hospital during March-June 2016 .The questionnaire was used to assess their knowledge , attitude and practices regarding adverse drug reaction reporting. A questionnaire comprising of 20 questions was distributed to interns, resident doctors and nurses.
Result: 83% interns, 88% resident doctors and 50 % nurses were aware about the definition of adverse drug reactions and 60% interns,73% resident doctors and 53% nurses had come across adverse drug reaction but they had not reported ADR because they did not know how and where to report suspected ADR and they were afraid of damage to their professional image and thought they may land up into legal issues. 55 % participants had shared the information regarding ADRs with senior physicians but they had not received training on ADR reporting in their curriculum. 96.5% interns, 72% resident doctors and 88.93% nurses opined that to improve the ADR reporting, it is essential to conduct pharmacovigilance workshops and seminars.
Conclusion: The results of the study show that there is a need to create awareness in interns, resident doctors and nurses regarding suspected ADR reporting. Factors discouraging reporting of suspected ADR can be overcome by appropriate educational interventions. There is a need for regular training and reinforcement of guidelines for ADR reporting among health care personnel.
Keywords: Adverse drug reaction; Attitude; Knowledge; Practices; Barriers.
References
1. British Medical Association. Reporting adverse drug reactions: a guide for healthcare professionals. In Reporting adverse drug reactions: a guide for healthcare professionals 2006 May.Available from http://www.isoponline.org/wp-content/uploads/2015/01/BMAreport.pdf accessed on 25/03/17
2. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC clinical pharmacology. 2009 Dec 1;9(1):14.
3. World Health Organization. The importance of pharmacovigilance.2002 available from http://apps.who.int/medicinedocs/pdf/s4893e/s4893e.pdf accessed on 25/03/2017
4. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactionsin a south Indian hospital – Their severity and cost involved. Pharmacoepidemiol Drug Saf 2003;12: 687‑92.
5. Reddy VL, Pasha SJ, Rathinavelu M, Reddy YP. Assessment of knowledge, attitude and perception of pharmacovigi-lance and adverse drug reaction (ADR) reporting among the pharmacy students in south India. IOSR J Pharm Biol Sci. 2014;9(2):34-43.
6. World Health Organization. International drug monitoring: the role of national centres, report of a WHO meeting [held in Geneva from 20 to 25 September 1971]. Available from https://www.who-umc.org/media/2680/who-technical-report-498.pdf Accessed on 01/03/27
7. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Bmj. 2004 Jul 1;329(7456):15-9.
8. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998 Apr 15;279(15):1200-5.
9. The importance of pharmacovigilance. Safety monitoring of medicinal products. Geneva: World Health Organization; World Health Organization Collaborating Centre for International Drug Monitoring; 2002
10. Pharmacovigilance programme of India 2010. CDSCO, Ministry of Health and Family Welfare, Government of India; 2010.available from http://www.cdsco.nic.in/forms/contentpage1.aspx?lid=1752 accessed on 05/03/17
11. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions. Drug safety. 2009 Jan 1;32(1):19-31.
12. Ulfvarson J, Mejyr S, Bergman U. Nurses are increasingly involved in pharmacovigilance in Sweden. Pharmacoepidemiology and drug safety. 2007 May 1;16(5):532-7.
13. Inman WHW,Assessment drug safety problems. In: Gent M, Shigmatsu I, editors. Epidemiological issues in reported drug-induced illnesses. Honolulu, Ontario: McMaster University Library Press; 1976. p. 17-24
14. Belton K, Lewis S & Payne S et al Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. British Journal of Clinical Pharmacology 1995: 39 : 223-6.
15. Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res 2011 :2: 129-136
16. Pimpalkhute SA, Jaiswal KM, Suntakke SD, Bajait CS, Gaikwad A. Evaluation of a awareness about pharmacovigilance and adverse dryg reaction monitoring in resident doctors of a tertiary care teaching hospital. Indian J Med Sci 2012; 66:55-61).
17. Bateman DN, Sanders GL, Rawlins MD. Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol. 1992;34:421‐6.
18. Milstein JB, Faich GA, Hsu JP. Factors affecting physician reporting of adverse drug reactions. Drug Inf J. 1986;20:157‐64.
19. Vivekanandan Kalaiselvan, Prasad Thota, Gyanendra Nath Singh, Pharmacovigilance Programme of India: Recent developments and future perspectives ,Indian Journal of Pharmacology Year : 2016, Volume : 48, Issue : 6,Page : 624-628
20. Ramesh M, Parthasarathi G :Adverse drug reactions reporting: attitudes and perceptions of medical practitioners. Asian J Pharm Clin Res 2009:2: 10-4.)
21. Hazell L, Shakir SA. Under‐reporting of adverse drug reactions: A systematic review. Drug Saf. 2006;29:385‐96.
22. Morrison-Griffiths S, Walley T & Park B et al ,Reporting of adverse drug reactions by nurses. The Lancet :2003 361:1347.
23. Bäckström M, Ekman E, Mjörndal T Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol,2007: 63: 613-618.
24. Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Therapeutic advances in drug safety. 2016 Feb;7(1):11-22.